Advanced in Premature Infant

Dr. Carl T. D'angio

Neonatology
601 Elmwood Ave, Box 635, 
Rochester, NY 
Clinical Trials:Currently Recruiting for 2 Trials
Advanced in Premature Infant
601 Elmwood Ave, Box 635, 
Rochester, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Carl D'angio is a Neonatologist in Rochester, New York. Dr. D'angio is rated as an Advanced provider by MediFind in the treatment of Premature Infant. His top areas of expertise are Premature Infant, Bronchopulmonary Dysplasia, Infant Respiratory Distress Syndrome, and Necrotizing Enterocolitis.

His clinical research consists of co-authoring 69 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 40 articles in the study of Premature Infant.

Specialties
Neonatology
Licenses
Pediatrics in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Managed Medicaid
  • OTHER MANAGED MEDICAID

Locations

601 Elmwood Ave, Box 635, Rochester, NY 14642

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

12 Clinical Trials

Generic Database: A Survey of Morbidity and Mortality in Very Low Birth Weight Infants
Generic Database: A Survey of Morbidity and Mortality in Very Low Birth Weight Infants
Enrollment Status: Recruiting
Publish Date: February 13, 2025
Intervention Type: Other
Follow-up Visit of High Risk Infants
Follow-up Visit of High Risk Infants
Enrollment Status: Recruiting
Publish Date: February 13, 2025
Intervention Type: Other
Cycled Phototherapy: A Safer Effective Method to Control the Serum Bilirubin Of Extremely Premature Infants?
Cycled Phototherapy: A Safer Effective Method to Control the Serum Bilirubin Of Extremely Premature Infants?
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2025
Intervention Type: Device
Study Phase: Not Applicable
Management of the Patent Ductus Arteriosus in Premature Infants Trial (PDA Trial)
Management of the Patent Ductus Arteriosus in Premature Infants Trial (PDA Trial)
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Other
Study Phase: Phase 3
Randomized Controlled Trial of Budesonide + Surfactant Versus Surfactant Alone in Extremely Preterm Infants (The Budesonide in Babies (BiB) Trial)
Randomized Controlled Trial of Budesonide + Surfactant Versus Surfactant Alone in Extremely Preterm Infants (The Budesonide in Babies (BiB) Trial)
Enrollment Status: Active_not_recruiting
Publish Date: July 23, 2025
Intervention Type: Drug
Study Drugs: Budesonide (Pulmicort Nebulizing Suspension), Surfactant (Poractant Alfa
Study Phase: Phase 3
A Randomized Controlled Trial of the Effect of Hydrocortisone on Survival Without Bronchopulmonary Dysplasia and on Neurodevelopmental Outcomes at 22 - 26 Months of Age in Intubated Infants < 30 Weeks Gestation Age
A Randomized Controlled Trial of the Effect of Hydrocortisone on Survival Without Bronchopulmonary Dysplasia and on Neurodevelopmental Outcomes at 22 - 26 Months of Age in Intubated Infants < 30 Weeks Gestation Age
Enrollment Status: Completed
Publish Date: February 27, 2025
Intervention Type: Drug
Study Drug: Hydrocortisone
Study Phase: Phase 3
A Randomized Trial of Targeted Temperature Management With Whole Body Hypothermia For Moderate And Severe Hypoxic-Ischemic Encephalopathy In Premature Infants 33-35 Weeks Gestational Age.
A Randomized Trial of Targeted Temperature Management With Whole Body Hypothermia For Moderate And Severe Hypoxic-Ischemic Encephalopathy In Premature Infants 33-35 Weeks Gestational Age.
Enrollment Status: Completed
Publish Date: November 04, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants
Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants
Enrollment Status: Active_not_recruiting
Publish Date: October 30, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
A Multi-center Randomized Trial of Laparotomy vs. Drainage as the Initial Surgical Therapy for ELBW Infants With Necrotizing Enterocolitis (NEC) or Isolated Intestinal Perforation (IP): Outcomes at 18-22 Months Adjusted Age
Enrollment Status: Completed
Publish Date: July 18, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Transfusion of Prematures (TOP) Trial: Does a Liberal Red Blood Cell Transfusion Strategy Improve Neurologically-Intact Survival of Extremely-Low-Birth-Weight Infants as Compared to a Restrictive Strategy?
Transfusion of Prematures (TOP) Trial: Does a Liberal Red Blood Cell Transfusion Strategy Improve Neurologically-Intact Survival of Extremely-Low-Birth-Weight Infants as Compared to a Restrictive Strategy?
Enrollment Status: Active_not_recruiting
Publish Date: March 22, 2024
Intervention Type: Procedure
Study Phase: Phase 3
Neurodevelopmental Effects of Donor Human Milk vs. Preterm Formula in Extremely Low Birth Weight (ELBW) Infants
Neurodevelopmental Effects of Donor Human Milk vs. Preterm Formula in Extremely Low Birth Weight (ELBW) Infants
Enrollment Status: Completed
Publish Date: February 06, 2023
Intervention Type: Biological, Dietary supplement
Study Drug: Donor Breast Milk
Study Phase: Phase 3
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Early-Onset Sepsis an NICHD/CDC Surveillance Study
Enrollment Status: Completed
Publish Date: March 11, 2019
View 10 Less Clinical Trials

69 Total Publications

Early Intratracheal Budesonide to Reduce Bronchopulmonary Dysplasia in Extremely Preterm Infants: The Budesonide in Babies (BiB) Randomized Clinical Trial.
Early Intratracheal Budesonide to Reduce Bronchopulmonary Dysplasia in Extremely Preterm Infants: The Budesonide in Babies (BiB) Randomized Clinical Trial.
Journal: JAMA
Published: September 30, 2025
Similar Doctors
Elite in Premature Infant
Dr. Sanjiv B. Amin
Neonatology | Pediatrics
Elite in Premature Infant
Dr. Sanjiv B. Amin
Neonatology | Pediatrics
601 Elmwood Ave, Box 635, 
Rochester, NY 
 (0.1 miles away)
585-275-7787
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Sanjiv Amin is a Neonatologist and a Pediatrics provider in Rochester, New York. Dr. Amin is rated as a Distinguished provider by MediFind in the treatment of Premature Infant. His top areas of expertise are Jaundice, Premature Infant, Transient Familial Hyperbilirubinemia, and Bilirubin Encephalopathy. Dr. Amin is currently accepting new patients.

Elite in Premature Infant
Dr. Gloria S. Pryhuber
Neonatology
Elite in Premature Infant
Dr. Gloria S. Pryhuber
Neonatology
601 Elmwood Ave, Box 635, 
Rochester, NY 
 (0.1 miles away)
585-275-7787
Languages Spoken:
English

Gloria Pryhuber is a Neonatologist in Rochester, New York. Dr. Pryhuber is rated as a Distinguished provider by MediFind in the treatment of Premature Infant. Her top areas of expertise are Bronchopulmonary Dysplasia, Premature Infant, Cerebral Hypoxia, and High Blood Pressure in Infants.

Advanced in Premature Infant
Dr. Ronnie Guillet
Neonatology
Advanced in Premature Infant
Dr. Ronnie Guillet
Neonatology
601 Elmwood Ave, Box 635, 
Rochester, NY 
 (0.1 miles away)
585-275-7787
Languages Spoken:
English

Ronnie Guillet is a Neonatologist in Rochester, New York. Dr. Guillet is rated as an Advanced provider by MediFind in the treatment of Premature Infant. Her top areas of expertise are Premature Infant, Anemia, Patent Ductus Arteriosus, and Hypothermia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. D'angio's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile